David Monticone
Obstetrics & Gynecology · El Paso, TXNPI 1891783528
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 150 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $685 and has fallen 53.4% since, to $319 in 2025.
Across 150 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$512
- Bayer$441
- Exeltis, USA Inc.$332
- Avion Pharmaceuticals$278
- Medtronic$143
- Astellas Pharma US Inc$133
- plus $843 from 20 others
What the payments were for
- Food & beverage$2,59497%
- Education$883%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $512 |
| Bayer | 25 | $441 |
| Exeltis, USA Inc. | 19 | $332 |
| Avion Pharmaceuticals | 20 | $278 |
| Medtronic | 1 | $143 |
| Astellas Pharma US Inc | 4 | $133 |
| Coopersurgical, Inc. | 7 | $108 |
| Organon | 7 | $89 |
| Therapeuticsmd, Inc. | 5 | $81 |
| Daiichi Sankyo Inc. | 3 | $73 |
| Mayne Pharma Commercial LLC | 3 | $64 |
| Lupin Inc. | 4 | $57 |
| Shield Therapeutics Inc | 3 | $57 |
| Hologic Sales And Service, LLC | 3 | $49 |
| Sage Therapeutics, LLC | 3 | $45 |
| Pfizer | 2 | $40 |
| Vertical Pharmaceuticals, LLC | 2 | $34 |
| Merck | 2 | $32 |
| AMAG Pharmaceuticals, Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Myriad Women's Health, Inc. | 1 | $15 |
| Agile Therapeutics, Inc. | 1 | $14 |
| Smith+Nephew | 1 | $14 |
| Mission Pharmacal Company | 1 | $14 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
| Alydia Health | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$143
How this compares
$2,682 in reported general payments places this provider in the 70th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxyzine Hcl | 11 | $64 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in El Paso
- Robert AsgharianEl Paso$366K
- Mario NutisEl Paso$69K
- Michiel NoeEl Paso$51K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.